Jeffrey A. Porter

发表

Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans

M. Yassour, C. Huttenhower, E. Franzosa, 2016, Cell.

Gut microbiome structure and metabolic activity in inflammatory bowel disease

C. Huttenhower, E. Franzosa, T. Vatanen, 2018, Nature Microbiology.

High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions.

John A. Tallarico, Jeffrey A. Porter, Mathias Frederiksen, 2014, Microbiological research.

Pathway Reporter Assays Reveal Small Molecule Mechanisms of Action

Douglas W. Selinger, Frederick J. King, Felipa A. Mapa, 2009 .

Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation.

Daniel J. O'Connell, C. Huttenhower, E. Franzosa, 2017, Cell host & microbe.

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Jeffrey P. MacKeigan, Charles Kung, Bailin Zhang, 2009, Cell.

Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans

Tommi Vatanen, Raivo Kolde, Harri Lähdesmäki, 2016, Cell.

Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Jeffrey A. Porter, P. Grandi, H. Ruffner, 2014, Nature chemical biology.

Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life

Philipp C. Münch, M. Yassour, C. Huttenhower, 2018, Nature Microbiology.

Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R‐spondin

Sheri K. Wilcox, Jeffrey A. Porter, P. Lemotte, 2013, EMBO reports.

Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors.

D. Plichta, H. Vlamakis, Jeffrey A. Porter, 2021, Cell host & microbe.

Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis.

Daniel S. Hitchcock, C. Huttenhower, E. Franzosa, 2019, Cell host & microbe.

Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing

A. Regev, Jeffrey A. Porter, R. Xavier, 2022, PLoS biology.

Gut microbiome structure and metabolic activity in inflammatory bowel disease

C. Huttenhower, E. Franzosa, T. Vatanen, 2018, Nature Microbiology.

Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth.

Jeffrey A. Porter, W. Sellers, Christopher J. Wilson, 2012, Cancer discovery.

Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in Inflammatory Bowel Disease

Andrew C. Tolonen, C. Huttenhower, E. Franzosa, 2019, Nature Microbiology.

PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling.

John A. Tallarico, Jeffrey A. Porter, P. De Camilli, 2013, Chemistry & biology.

Defective Autophagy and mTORC1 Signaling in Myotubularin Null Mice

Jeffrey A. Porter, P. Finan, K. Walsh, 2012, Molecular and Cellular Biology.

1 Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research,

Jeffrey A. Porter, P. Finan, K. Walsh, 2012 .

Signaling in Myotubularin Null Mice Defective Autophagy and mTORC 1

Jeffrey A. Porter, P. Finan, K. Walsh, 2012 .

Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life

Philipp C. Münch, M. Yassour, C. Huttenhower, 2018, Nature Microbiology.

Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease

C. Huttenhower, E. Franzosa, T. Vatanen, 2019, Nature Microbiology.

Metabolic Enzyme Sulfotransferase 1A1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth Suppression.

Jeffrey A. Porter, K. Venkatesan, Christopher J. Wilson, 2015, Chemistry & biology.

Gut bacterial metabolites modulate endoplasmic reticulum stress

H. Vlamakis, Jeffrey A. Porter, R. Xavier, 2021, Genome biology.

Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin

John A. Tallarico, E. Winzeler, S. Meister, 2012, Cell host & microbe.

A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia

Jeffrey A. Porter, T. Bouwmeester, K. Mansfield, 2017, Science Signaling.

CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency

Jeffrey A. Porter, R. Dolmetsch, T. Bouwmeester, 2016, Science.

Metabolic Enzyme Sulfotransferase 1 A 1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth Suppression Highlights

Jeffrey A. Porter, K. Venkatesan, Christopher J. Wilson, 2022 .

An Integrated Approach for Identification and Target Validation of Antifungal Compounds Active against Erg11p

Jeffrey A. Porter, Mathias Frederiksen, S. Reinker, 2012, Antimicrobial Agents and Chemotherapy.

Abstract LB-017: Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to marked dependence on PRMT5

Konstantinos J. Mavrakis, Jeffrey A. Porter, W. Sellers, 2016 .